USAS Building System Listed on the Hong Kong Stock Exchange: A Top-Three Industrial Prefabricated Steel Structure Solution Provider Enters a New Phase in the Capital Markets 
DEFSEC Technologies Inc. Announces Full Year Fiscal 2025 Results and Outlook for Fiscal 2026 
The FUTR Corporation Announces Enterprise Agreement with Direct Wholesale Rates to Expand AI-Powered Mortgage, Payments, and Home Concierge Services in the U.S. 
Pineapple Financial Appoints Anthony Georgiades to Board of Directors and Special Advisory Committee 
Gatekeeper Reports $31.8M Revenue in Fiscal 2025 Osmotica Pharmaceuticals plc to Provide Fourth Quarter and Full Year 2020 Business and Financial Update on March 30, 2021
BRIDGEWATER, N.J., March 24, 2021 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or…
Mustang Bio Reports Full-Year 2020 Financial Results and Recent Corporate Highlights
NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a…
AgraFlora Provides Dial-In Information for Annual General Meeting and Business Update Presentation
VANCOUVER, British Columbia, March 24, 2021 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“AgraFlora” or…
Sana Biotechnology Reports Fourth Quarter and 2020 Financial Results and Business Updates
Expects to present data at multiple scientific conferences in 2021 2020 year-end cash position of…
Equillium Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical Development Update
Cash runway into the second half of 2023 Announced positive interim data from EQUATE study…
MediWound Hosting Analyst Day Webinar on EscharEx – Enzymatic Debridement Agent for Chronic Wounds
Webinar To Be Held on Tuesday, March 30th at 10am Eastern Time YAVNE, Israel, March…
89bio Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
– Initiation of BIO89-100 Phase 2b NASH trial planned in 1H21 – – NASH histology…
Abeona Therapeutics Announces 2020 Financial Results and Recent Operational Progress
Fourth patient treated in pivotal Phase 3 VIITAL™ study of EB-101 in RDEB after successful…
TELA Bio Announces Fourth Quarter and Full Year 2020 Financial Results
MALVERN, Pa., March 24, 2021 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical…
Galapagos appoints Bart Filius as President and Chief Operating Officer
Mechelen, Belgium; 24 March 2021; 21.01 CET; Galapagos (Euronext & Nasdag; GLPG) announced today that…
Tauriga Sciences Inc. Expands its Pet Treats Product Offerings to 3 SKUs (Branded as: Tauri-Pet)
03_24 PR Image The 3 Distinct Tauri-Pet™ SKUs Commercial Launch of Tauri-Pet™ Product Line is…
Guerbet: 2020 annual results
2020 annual results Revenue in line with forecasts despite the health crisis: -12.8% at current…
Alliance for Regenerative Medicine Supports the Council Position on EU Joint Clinical Assessments
Alliance for Regenerative Medicine Supports the Council Position on EU Joint Clinical Assessments European Patients…
Fulcrum Therapeutics Appoints Judith A. Dunn, Ph.D. as President of Research and Development
CAMBRIDGE, Mass., March 24, 2021 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical…
HUTCHMED Enters Agreement to Divest Non-Core OTC Joint Venture for US$169 Million
Allows focus on China and global clinical development and market launches of key Oncology/Immunology assets HONG…
AXIM® Biotechnologies’ Manufacturing Partner Empowered Diagnostics Files Emergency Use Authorization With FDA for Use of Its Rapid COVID-19 Neutralizing Antibody Test in Whole Blood at Point-of-Care Locations
SAN DIEGO, March 24, 2021 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,”…
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19
TORONTO, March 24, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:…
ORYZON Publishes Vafidemstat First-in-Human Clinical Trial Manuscript in CNS Drugs Journal
Vafidemstat displayed good safety and tolerability in healthy young and elderly volunteers Paper confirms vafidemstat…
Arch Biopartners Enters Exclusive License Agreement with the University of Cincinnati for AB569 Topical Wound Treatment
TORONTO, March 24, 2021 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX…
Praxis Precision Medicines to Present at Stifel’s 3rd Annual CNS Day
CAMBRIDGE, Mass., March 24, 2021 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a…